69 results
Page 3 of 4
424B5
2psuo v2h
19 Jan 21
Prospectus supplement for primary offering
4:12pm
S-3
x1j9acj
11 Aug 20
Shelf registration
7:58am
D
darqhli
11 Jun 20
$68.5M in equity, sold $68.5M, 13 investors
12:00am
DEFA14A
qskm8t
29 Apr 20
Additional proxy soliciting materials
9:24am
DEF 14A
vkc20i
29 Apr 20
Definitive proxy
9:21am
10-K
EX-10.17
2gtrh x88a2eew96
5 Mar 20
Annual report
4:01pm
10-K
3fk4fk
5 Mar 20
Annual report
4:01pm
8-K
3o5eqka
4 Oct 19
Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD
6:08am
10-Q
6bnnj 11f6m81
26 Aug 19
Quarterly report
7:43am
8-K
EX-3.2
luore7efsowii8jpd
22 Jul 19
Amendments to Articles of Incorporation or Bylaws
4:10pm
424B4
fc933l1 1j325fz
18 Jul 19
Prospectus supplement with pricing info
5:19pm
S-1/A
5urkny78s1oy5m
8 Jul 19
IPO registration (amended)
6:04am
S-1
hzl z795qbk
21 Jun 19
IPO registration
4:26pm
S-1
EX-10.5
cysoztli7ir8bblixo9r
21 Jun 19
IPO registration
4:26pm
S-1
EX-3.4
cyqguae
21 Jun 19
IPO registration
4:26pm